Home Ventana, Halozyme partner to develop companion diagnostic assay for cancer treatment
 

Keywords :   


Ventana, Halozyme partner to develop companion diagnostic assay for cancer treatment

2015-05-31 03:08:15| Biotech - Topix.net

Halozyme Therapeutics, Inc. and Ventana Medical Systems, Inc. , a member of the Roche Group, announced today a global agreement to collaborate on the development of, and for Ventana to ultimately commercialize, a companion diagnostic assay for use with Halozyme's investigational new drug, PEGPH20. The Ventana assay will be used to identify high levels of hyaluronan .

Tags: partner treatment develop cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.06Potential Tropical Cyclone One Graphics
18.06Potential Tropical Cyclone One Public Advisory Number 3A
18.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
18.06Post Office sabotaged Horizon probe, says investigator
18.06Atlantic Tropical Weather Outlook
18.06Eastern North Pacific Tropical Weather Outlook
18.06Farm Progress America, June 18, 2024
18.06Farm Progress America, June 18, 2024
More »